Mild Hip Dysplasia

NCT03530878 | Withdrawn

• 1 other identifier: 17-007229
• Study Type: interventional
• Target: N/A
• Locations: 0 countries
• Sites: N/A

Brief Summary

Hip dysplasia is a complex problem that exists on a spectrum from mild to severe disease. Periacetabular osteotomy (PAO) remains the gold standard for most patients with dysplasia; however, the procedure is quite invasive making the decision to proceed in cases of mild disease difficult. Hip arthroscopy (HA) is an alternative minimally invasive technique that can be used to address mild dysplasia. Nevertheless, HA has less capability for correction and in rare instances can exacerbate instability in the dysplastic hip. There is a paucity of data examining outcomes between these two treatment strategies for this challenging problem.

Conditions

Hip Dysplasia

Outcome Measures

Primary Outcomes (1)

• The Forgotten Joint Score-12 (FJS-12)

  Outcome

  1 year

Study Arms (2)

Hip Arthroscopy (HA)

EXPERIMENTAL

This approach addresses intraarticular pathology in the form of labral tears and cartilage that are often concomitant with DDH 3. Furthermore, capsular plication can be performed through HA to reduce instability of the joint.

Procedure: Hip Arthroscopy

Periacetabular Osteootmy (PAO)

NO INTERVENTION

The Bernese periacetabular osteotomy (PAO) remains the gold standard for treatment of symptomatic developmental dysplasia of the hip (DDH) in most patients with closed triradiate cartilage. First developed by Ganz in 1984, this technique utilizes 4 osteotomies to completely mobilize the acetabular fragment 1. Although a technically demanding procedure, it allows optimal correction in all planes and maintains integrity of the posterior column, enabling early weight bearing and mobilization.

Interventions

Hip Arthroscopy PROCEDURE

Intraarticular pathology in the form of labral tears and cartilage that are often concomitant with DDH

Hip Arthroscopy (HA)

Eligibility Criteria

• Age: 18 Years - 45 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Diagnosis of symptomatic mild DDH
• Lateral center-edge angle 18° - 25° and/or Tӧnnis angle 8° - 15°
• Skeletally mature
• Age 18 - 45
• Tonnis Grade 0 or 1 osteoarthritis (minimal or no arthritis)
• Ability to receive a standard of care preoperative MRI arthrogram of the hip

You may not qualify if:

• Pregnant women
• Neurogenic dysplasia
• Legg-Calvé-Perthes disease
• Previous surgery about the hip including previous hip arthroscopy to address intra-articular pathology

Sponsors & Collaborators

• Mayo Clinic: lead

Related Links

• Mayo Clinic Clinical Trials

MeSH Terms

Conditions

Hip Dislocation

Condition Hierarchy (Ancestors)

Joint Dislocations; Joint Diseases; Musculoskeletal Diseases; Wounds and Injuries; Hip Injuries

Study Officials

• Rafael J Sierra

  Mayo Clinic

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Professor of Orthopedics

Study Record Dates

• First Submitted: April 9, 2018
• First Posted: May 21, 2018
• Study Start: June 1, 2018
• Primary Completion: January 11, 2019
• Study Completion: January 11, 2019
• Last Updated: February 26, 2019

Record last verified: 2019-02